AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+7.88%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.12B
AUM Growth
+$1.44B
(+86%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
43.59%
Top 10 Holdings %
Top 10 Hldgs %
70.07%
Holding
139
New
20
Increased
22
Reduced
20
Closed
25
Top Buys
| 1 |
CAVA Group
CAVA
|
$1.31B |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$63.6M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$38.1M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$20.4M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$18.7M |
Top Sells
| 1 |
WW
WW International
WW
|
$61.1M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$15.8M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.1M |
| 4 |
Fate Therapeutics
FATE
|
$14.8M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$13.1M |
Sector Composition
| 1 | Healthcare | 56.49% |
| 2 | Consumer Discretionary | 42.78% |
| 3 | Technology | 0.24% |
| 4 | Financials | 0.2% |
| 5 | Real Estate | 0.17% |
